Welcome to Journal of Hepatocellular Carcinoma

Por Kaseb, Ahmed O
Publicado no J Hepatocell Carcinoma (2015)

Pretreatment assessment of hepatocellular cancer: expert consensus conference

Por Wilson, Stephanie R, Greig, Paul, Kaseb, Ahmed O
Publicado em 2010

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing

Por Janku, Filip, Kaseb, Ahmed O., Tsimberidou, Apostolia M., Wolff, Robert A., Kurzrock, Razelle
Publicado em 2014

Type I insulin-like growth factor receptor signaling in hematological malignancies

Por Vishwamitra, Deeksha, George, Suraj Konnath, Shi, Ping, Kaseb, Ahmed O., Amin, Hesham M.
Publicado no Oncotarget (2016)

Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma

Por Torres, Harrys A, Mahale, Parag, Miller, Ethan D, Oo, Thein H, Frenette, Catherine, Kaseb, Ahmed O
Publicado em 2013

Minimally invasive image-guided therapies for hepatocellular carcinoma

Por Abdelsalam, Mohamed E, Murthy, Ravi, Avritscher, Rony, Mahvash, Armeen, Wallace, Michael J, Kaseb, Ahmed O, Odisio, Bruno C
Publicado no J Hepatocell Carcinoma (2016)

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Por Ali, Mahmoud A, Lacin, Sahin, Abdel-Wahab, Reham, Uemura, Mark, Hassan, Manal, Rashid, Asif, Duda, Dan G, Kaseb, Ahmed O
Publicado no Onco Targets Ther (2017)

The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK(+) T-cell lymphoma

Por Vishwamitra, Deeksha, Curry, Choladda V, Alkan, Serhan, Song, Yao-Hua, Gallick, Gary E, Kaseb, Ahmed O, Shi, Ping, Amin, Hesham M
Publicado no Mol Cancer (2015)

Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers

Por Takeuchi, Satoshi, Rohren, Eric M., Abdel-Wahab, Reham, Xiao, Lianchun, Morris, Jeffrey S., Macapinlac, Homer A., Hassan, Manal M., Kaseb, Ahmed O.
Publicado no Eur J Nucl Med Mol Imaging (2016)

V-CLIP: Integrating plasma VEGF into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials

Por Kaseb, Ahmed O., Hassan, Manal M., Lin, E, Xiao, Lianchun, Kumar, Vikas, Pathak, Priyanka, Lozano, Richard, Rashid, Asif, Abbruzzese, James L., Morris, Jeffrey S.
Publicado em 2010

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

Por Abdel-Wahab, Reham, Shehata, Samir, Hassan, Manal M, Habra, Mouhammed A, Eskandari, Ghazaleh, Tinkey, Peggy T, Mitchell, Jennifer, Lee, Ju-Seog, Amin, Hesham M, Kaseb, Ahmed O
Publicado no J Hepatocell Carcinoma (2015)

Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients

Por Atta, Mohamed Magdi El-Sadek Ali, Atta, Hazem Mahmoud, Gad, Magdy Abdel-Mawgoud, Rashed, Laila Ahmad, Said, Ebada M, Hassanien, Sharaf El-Sayed Ali, Kaseb, Ahmed O
Publicado no J Hepatocell Carcinoma (2016)

I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score

Por Kaseb, Ahmed O., Abbruzzese, James L., Vauthey, Jean-Nicolas, Aloia, Thomas A., Abdalla, Eddie K., Hassan, Manal M., Lin, E., Xiao, Lianchun, El-Deeb, Adel S., Rashid, Asif, Morris, Jeffrey S.
Publicado em 2011

Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma

Por Kaseb, Ahmed O., Morris, Jeffrey S., Hassan, Manal M., Siddiqui, Adnan M., Lin, E, Xiao, Lianchun, Abdalla, Eddie K., Vauthey, Jean-Nicolas, Aloia, Thomas A., Krishnan, Sunil, Abbruzzese, James L.
Publicado em 2011

Validation of a preclinical model of diethylnitrosamine-induced hepatic neoplasia in Yucatan miniature pigs

Por Mitchell, Jennifer, Tinkey, Peggy T., Avritscher, Rony, Van Pelt, Carolyn, Eskandari, Ghazaleh, George, Suraj Konnath, Xiao, Lianchun, Cressman, Erik, Morris, Jeffrey S., Rashid, Asif, Kaseb, Ahmed O., Amin, Hesham M., Uthamanthil, Rajesh
Publicado no Oncology (2016)

Treatment outcome and prognostic indicators in 94 cases of fibrolamellar hepatocellular carcinoma

Por Kaseb, Ahmed O, Shama, Mohamed, Sahin, Ibrahim Halil, Nooka, Ajay, Hassabo, Hesham M, Vauthey, Jean-Nicolas, Aloia, Thomas, Abbruzzese, James L, Subbiah, Ishwaria M, Janku, Filip, Curley, Steven, Hassan, Manal M
Publicado em 2013

Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials

Por Subbiah, Ishwaria M., Falchook, Gerald S., Kaseb, Ahmed O., Hess, Kenneth R., Tsimberidou, Apostolia M., Fu, Siqing, Subbiah, Vivek, Hong, David S., Naing, Aung, Sarina, A. Piha-Paul, Akmal, Owais, Janku, Filip, Kurzrock, Razelle
Publicado no Oncotarget (2015)

Modified Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability...

Por Kaseb, Ahmed O., Shindoh, Junichi, Patt, Yehuda Z., Roses, Robert E., Zimmitti, Giuseppe, Lozano, Richard D., Hassan, Manal M., Hassabo, Hesham M., Curley, Steven A., Aloia, Thomas A., Abbruzzese, James L., Vauthey, Jean-Nicolas
Publicado em 2013

HER2/neu-directed therapy for biliary tract cancer

Por Javle, Milind, Churi, Chaitanya, Kang, HyunSeon C., Shroff, Rachna, Janku, Filip, Surapaneni, Rakesh, Zuo, Mingxin, Barrera, Christian, Alshamsi, Humaid, Krishnan, Sunil, Mishra, Lopa, Wolff, Robert A., Kaseb, Ahmed O., Thomas, Melanie B., Siegel, Abby B.
Publicado no J Hematol Oncol (2015)

Targeted Therapy of Advanced Gallbladder Cancer and Cholangiocarcinoma with Aggressive Biology: Eliciting Early Response Signals from Phase 1 trials

Por Subbiah, Ishwaria M., Subbiah, Vivek, Tsimberidou, Apostolia M., Naing, Aung, Kaseb, Ahmed O., Javle, Milind, Fu, Siqing, Hong, David S., Piha-Paul, Sarina, Wheler, Jennifer J., Hess, Kenneth R., Janku, Filip, Falchook, Gerald S., Wolff, Robert A, Kurzrock, Razelle
Publicado em 2013